England - London • TMT (technology, media and telecoms)
Kirkland & Ellis International LLP
‘Top-class’ Kirkland & Ellis International LLP maintains a strong IP offering, routinely handling high-stakes disputes, one notable example being the team’s representation of Pfizer and Regeneron in landmark judgments in the Supreme Court. The team of ’ferocious litigators’ also has experience of handling SEP/FRAND related litigation. On the transactional side, the team is involved in M&A deals, as well as multiple asset deals and carve-out transactions. Nicola Dagg spearheads the IP litigation practice, she has a wealth of experience in managing biotech patent litigations, as well as an expertise in emerging SEP/FRAND related work. Daniel Lim is noted for his ability to handle complex multijurisdictional patent litigation, often involving blockbuster life sciences and medical devices related matters, while IP litigator Steven Baldwin is well-versed in the high-tech and life sciences sectors. ‘Strategic thinker’ Jin Ooi fields a strong IP litigation practice, with his expertise in the biotechnology space. Emma Flett leads the firm’s technology and IP transactions team with her capabilities that encompass the full gamut of IP-related work, but especially in regard to high-value M&A transactions.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘The Kirkland team is incredibly talented, hard-working and works well as a coherent unit to bring about the best results for clients.’
‘Nicola Dagg is the head of the IP team and is a force of nature. Amazing at bringing the work in she effectively manages her team to keep all the plates spinning.'
- 'Jin Ooi has an extremely sharp eye for detail and a wonderful ability to connect points in a case. He is a deep and strategic thinker.'
- 'Daniel Lim has a rare ability to cross-over from patent regulatory to patent litigation. He is highly recommended for his experience in pharmaceutical patent litigation.’
- 'Steve Baldwin is a great lawyer who easily gets to grips with the most complex of telecoms litigation.’
‘Well resourced and capable team. There is real passion and dedication towards delivering a top-class service to clients.’
‘Kirkland & Ellis are pioneering litigators. They have a wealth of experience in the (legally and technically) most complex cases and are very much part of the cutting-edge litigation teams that are driving forward practice before the English courts. Their can-do attitude is second to none.'
‘K&E have enormous strength and enormous depth. Their reputation as ferocious litigators is well deserved, and their ability to create maximal pressure on opponents and to grasp strategic advantages when they arise is exceptional.’
Key clients
- Intel
- Lenovo & Motorola Mobility
- Pfizer
- Astellas
- British American Tobacco
- Alcon
- Novartis
- Regeneron Pharmaceuticals
- TCL Corporation
- Xiaomi
- AutoStore
- Samsung
- Viatris
- Meril Life Sciences
- Adaptive Spectrum and Signal Alignment Inc. (ASSIA)
- Advanced Bionics / Sonova
- Pharmathen
- Thales
Work highlights
- Representing Lenovo in a major worldwide SEP/FRAND licensing dispute between InterDigital and Lenovo / Motorola Mobility.
- Advising and representing Astellas and Pfizer in relation to the protection of the blockbuster life-saving and -extending prostate cancer treatment Xtandi®, which generates multiple billion dollars (and growing) in sales every year.
- Advising and representing Warner-Lambert, Pfizer, and Viatris (which now owns the LYRICA® portfolio) against the NHS in relation to the most complex follow-on damages inquiry ever to be heard before the Patents Court, raising novel issues of foreseeability, causation and mitigation.
Lawyers
Hall of Fame
The lawyers at the very top of the profession, widely known and respected by peers and clients for their longstanding involvement in market-leading work.
Next Generation Partners
Kirkland & Ellis LLP
Jin Ooi is an intellectual property litigator in the London office of Kirkland & Ellis International LLP. He is experienced in patent litigation and counselling (including on complex damages inquiries) mainly in the pharmaceutical and life sciences field (second medical use, biosimilars, small molecules, DNA sequencing, vaccines, transgenic animal platforms for antibody discovery), and in the consumer products sector (shaving razors, potentially reduced-risk products including tobacco heating and vapour products, dishwashing tablets, coffee pods and capsules). He is also experienced in litigating and arbitrating trade secrets disputes in the medical devices (bone cements), tech (LNG carriers) and aviation sector (airplane components, airport businesses), in addition to handling antitrust claims (cathode ray tubes, lithium ion batteries, forklift gas).
Practice head
The lawyer(s) leading their teams.
Nicola Dagg, Emma Flett